The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2026
Filed:
May. 07, 2020
Applicant:
Sator Therapeutics Llc, Cleveland, OH (US);
Inventors:
Peter M. Chumakov, Solon, OH (US);
Darya A. Berzhitskaya, Moscow, RU;
Anastasia V. Lipatova, Moscow, RU;
Stepan P. Chumakov, Moscow, RU;
Natalia D. Tararova, Gates Mills, OH (US);
Stephen A. Charles, Chagrin Falls, OH (US);
Anton A. Komar, Gates Mills, OH (US);
Assignee:
SATOR THERAPEUTICS LLC, Cleveland, OH (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0784 (2010.01); A61K 35/768 (2015.01); A61K 40/19 (2025.01); A61K 40/24 (2025.01); A61K 40/46 (2025.01); A61P 35/00 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0639 (2013.01); A61K 35/768 (2013.01); A61K 40/19 (2025.01); A61K 40/24 (2025.01); A61K 40/46 (2025.01); A61P 35/00 (2018.01); C12N 7/00 (2013.01); A61K 2239/31 (2023.05); A61K 2239/38 (2023.05); A61K 2239/47 (2023.05); A61K 2239/50 (2023.05);
Abstract
A versatile carrier system for systemic delivery of oncolytic viruses comprises dendritic cells having at least one oncolytic virus loaded therein. It is believed that the dendritic cells will protect the oncolytic virus(es) against neutralizing antibodies, can transport the oncolytic virus(es) to targeted tumor locations, and then deliver virions to the tumor locations.